Category: Regulations
-
Personalized Breast Cancer Trial Advances 7 Drugs
A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA.
-
Infographic – Nations with Most Organ Donors
Data from surveys conducted by the international polling company Ipsos show percentages of respondents willing to donate their organs upon their death.
-
FDA to Test New Trial Designs, Assess A.I. Models
FDA plans to pilot test new types of complex clinical trials and is considering a procedure to evaluate machine learning algorithms used in diagnostics.
-
Infographic – Smartphone Data Collection, Like It or Not
We’re learning more and more about the data collected by mobile device software, particularly Apple’s iOS and Google’s Android operating systems.
-
FDA Clears Magnetic Device for Obsessive Compulsive Disorder
A non-invasive device using magnetic waves that penetrate the brain to treat obsessive-compulsive disorder received authorization for sales in the U.S. from the Food and Drug Administration.
-
Infographic – 72,000 Opioid Overdose Deaths in 2017
A preliminary report from the Centers for Disease Control and Prevention shows that more than 72,000 deaths from opioid overdose were reported for 2017.
-
FDA Clears Fertility Awareness App for Birth Control
A mobile app for determining a woman’s fertility state on any given day was cleared for marketing in the U.S. as a birth control method.
-
Infographic – U.S. Falling Way Behind on 5G
The success of mobile devices depends on their underlying technologies, with the next generation of mobile standards known as 5G in the queue.
-
FDA Approves RNA-Interference Nerve Disease Therapy
A treatment that silences the actions of RNA and reverses damage to nerves from a rare inherited neurological disease was approved by the Food and Drug Administration.
-
Despite Crisis, U.S. Prescription Opioid Use Remains High
A review of insurance claims over a 10-year period shows prescription opioid use in the U.S. remains at a high level with few signs of declining, despite repeated and vocal public concerns about these drugs.